Author

Martin Mihm

Observed names: M. Mihm, Mihm M

OpenAlex ID: A5110079622

LBA2 Perioperative (periop) enfortumab vedotin (EV) plus pembrolizumab (pembro) in participants (pts) with muscle-invasive bladder cancer (MIBC) who are cisplatin-ineligible: The phase III KEYNOTE-905 study

2025 · C. Vulsteke, H. Kaimakliotis, et al. · Annals of Oncology · 46

3073P Enfortumab vedotin (EV) + pembrolizumab (P) in previously untreated locally advanced or metastatic urothelial cancer (la/mUC): An exploratory analysis in older patients (pts) and those with comorbidities from EV-302

2025 · N. Mar, S. Gupta, et al. · Annals of Oncology · 2

Works count: 3

Citation count: 47

H-index: 2

I10-index: 1